COGR, representing over 200 U.S. research institutions, submitted comments urging the withdrawal of the proposed Interagency Guidance Framework for Considering the...
Intellectual Property & Innovation
Covering policies and practices for federally sponsored research, Intellectual Property and Innovation ensures discoveries and creative works are effectively protected, managed, and commercialized.
Featured
Technology Transfer in U.S. Research Universities: Dispelling Common Myths (Updated August 2022)
This document, published by COGR, systematically addresses and dispels common misconceptions about technology transfer activities within U.S. research universities...
The Bayh-Dole Act: A Guide to the Law and Implementing Regulations (October 2021 Update)
Originally published in 1999, and updated October 2021:
Resources
Point of Contact
Kevin Wozniak
Director, Research Security & Intellectual Property
All Intellectual Property & Innovation Articles
COGR Joins C4IP in Urging the Biden Administration to Oppose the Proposed WTO IP Waiver for Covid-19 Therapeutics and Diagnostics
The letter, dated December 4, 2023, is addressed to President Joseph R. Biden by the Council for Innovation Promotion, a bipartisan group comprised of former senior government officials, university technology transfer experts, and leaders from trade and health sectors. The signatories urge President Biden to oppose the World Trade Organization's proposed waiver of intellectual property (IP) r
Results of Intellectual Property and Technology Transfer Sub-group Survey (NFRI)
The Intellectual Property and Technology Transfer Sub-group Survey, conducted on May 14, 2018, gathered input from forty respondents representing both research funding and research-performing entities. The survey explored a wide spectrum of issues pertinent to IP management and technology transfer agreements. Key topics included scope and ownership of intellectual property, disclosure procedures,
Intellectual Property and Technology Transfer Group Report-Out (NFRI)
The Intellectual Property and Technology Transfer Group conducted a survey and breakout discussion to assess the prevalence and negotiation dynamics of various IP provisions in research agreements. Survey responses, representing both funding (27.5%) and performing (72.5%) entities, indicated that some topics, such as invention disclosure and conflict of interest policies, are rarely contentious an
COGR Testimony at NIH Hearings on March-in Rights
NIH has denied the request from Essential Inventions, Inc. to exercise march-in rights under The Bayh-Dole Act in connection with the pricing of Norvir, marketed by Abbott Laboratories for the treatment of patients with HIV/AIDS. The decision and related materials are available online.
